US Stock MarketDetailed Quotes

Unicycive Therapeutics (UNCY)

Watchlist
  • 8.080
  • +0.100+1.25%
Close May 5 16:00 ET
  • 8.180
  • +0.100+1.24%
Pre 07:02 ET
215.74MMarket Cap-4.84P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Unicycive Therapeutics (UNCY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.10%29.52M
-22.00%7.22M
17.45%7.34M
-5.92%6.96M
-13.20%7.99M
49.74%32.12M
46.70%9.26M
5.27%6.25M
71.24%7.4M
88.72%9.2M
Selling and administrative expenses
68.52%20.4M
25.20%4.97M
36.56%4.38M
105.80%5.21M
143.33%5.82M
41.61%12.1M
91.01%3.97M
24.94%3.21M
23.26%2.53M
29.45%2.39M
-General and administrative expense
68.52%20.4M
25.20%4.97M
36.56%4.38M
105.80%5.21M
143.33%5.82M
41.61%12.1M
91.01%3.97M
24.94%3.21M
23.26%2.53M
29.45%2.39M
Research and development costs
-54.43%9.12M
-57.45%2.25M
-2.66%2.96M
-64.05%1.75M
-68.13%2.17M
55.12%20.01M
24.92%5.29M
-9.70%3.05M
114.73%4.87M
124.85%6.81M
Operating profit
8.10%-29.52M
22.00%-7.22M
-17.45%-7.34M
5.92%-6.96M
13.20%-7.99M
-54.60%-32.12M
-46.70%-9.26M
-5.27%-6.25M
-71.24%-7.4M
-119.04%-9.2M
Net non-operating interest income expense
-20.92%941K
10.20%324K
-34.16%264K
-68.16%142K
330.61%211K
123.26%1.19M
142.98%294K
91.87%401K
120.79%446K
2,350.00%49K
Non-operating interest income
-19.75%1.01M
11.78%351K
-32.93%279K
-66.45%155K
227.54%226K
105.04%1.26M
124.29%314K
83.26%416K
97.44%462K
392.86%69K
Non-operating interest expense
0.00%71K
35.00%27K
0.00%15K
-18.75%13K
-25.00%15K
-13.41%71K
5.26%20K
-16.67%15K
-50.00%16K
66.67%20K
Other net income (expense)
134.83%2.02M
38.14%-7.77M
-39.17%1.07M
-97.78%374K
170.70%8.35M
43.69%-5.8M
-681.94%-12.56M
25.64%1.75M
5,860.99%16.81M
-13.81%-11.81M
Gain on sale of security
134.83%2.02M
38.14%-7.77M
-39.17%1.07M
-97.78%374K
170.70%8.35M
43.69%-5.8M
-681.94%-12.56M
25.64%1.75M
5,860.99%16.81M
-13.81%-11.81M
Income before tax
27.70%-26.56M
31.86%-14.67M
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
Income tax
Net income
27.70%-26.56M
31.86%-14.67M
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
Net income continuous Operations
27.70%-26.56M
31.86%-14.67M
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
Minority interest income
Net income attributable to the parent company
27.70%-26.56M
31.86%-14.67M
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
Preferred stock dividends
26.30%1.1M
0
47.10%887K
8.33%208K
Other preferred stock dividends
0
60K
5.93M
0
Net income attributable to common stockholders
29.79%-26.56M
31.86%-14.67M
-46.75%-6.01M
-311.86%-6.45M
102.41%510K
-20.42%-37.82M
-176.03%-21.53M
7.01%-4.1M
168.52%3.04M
-43.37%-21.17M
Basic earnings per share
70.44%-1.67
56.63%-0.82
28.26%-0.33
-165.00%-0.52
0
55.86%-5.65
-18.17%-1.8908
64.62%-0.46
127.59%0.8
37.11%-6.1
Diluted earnings per share
70.44%-1.67
56.63%-0.82
28.26%-0.33
65.33%-0.52
91.80%-0.5
55.86%-5.65
-18.17%-1.8908
64.62%-0.46
48.28%-1.5
37.11%-6.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.10%29.52M-22.00%7.22M17.45%7.34M-5.92%6.96M-13.20%7.99M49.74%32.12M46.70%9.26M5.27%6.25M71.24%7.4M88.72%9.2M
Selling and administrative expenses 68.52%20.4M25.20%4.97M36.56%4.38M105.80%5.21M143.33%5.82M41.61%12.1M91.01%3.97M24.94%3.21M23.26%2.53M29.45%2.39M
-General and administrative expense 68.52%20.4M25.20%4.97M36.56%4.38M105.80%5.21M143.33%5.82M41.61%12.1M91.01%3.97M24.94%3.21M23.26%2.53M29.45%2.39M
Research and development costs -54.43%9.12M-57.45%2.25M-2.66%2.96M-64.05%1.75M-68.13%2.17M55.12%20.01M24.92%5.29M-9.70%3.05M114.73%4.87M124.85%6.81M
Operating profit 8.10%-29.52M22.00%-7.22M-17.45%-7.34M5.92%-6.96M13.20%-7.99M-54.60%-32.12M-46.70%-9.26M-5.27%-6.25M-71.24%-7.4M-119.04%-9.2M
Net non-operating interest income expense -20.92%941K10.20%324K-34.16%264K-68.16%142K330.61%211K123.26%1.19M142.98%294K91.87%401K120.79%446K2,350.00%49K
Non-operating interest income -19.75%1.01M11.78%351K-32.93%279K-66.45%155K227.54%226K105.04%1.26M124.29%314K83.26%416K97.44%462K392.86%69K
Non-operating interest expense 0.00%71K35.00%27K0.00%15K-18.75%13K-25.00%15K-13.41%71K5.26%20K-16.67%15K-50.00%16K66.67%20K
Other net income (expense) 134.83%2.02M38.14%-7.77M-39.17%1.07M-97.78%374K170.70%8.35M43.69%-5.8M-681.94%-12.56M25.64%1.75M5,860.99%16.81M-13.81%-11.81M
Gain on sale of security 134.83%2.02M38.14%-7.77M-39.17%1.07M-97.78%374K170.70%8.35M43.69%-5.8M-681.94%-12.56M25.64%1.75M5,860.99%16.81M-13.81%-11.81M
Income before tax 27.70%-26.56M31.86%-14.67M-46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M
Income tax
Net income 27.70%-26.56M31.86%-14.67M-46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M
Net income continuous Operations 27.70%-26.56M31.86%-14.67M-46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M
Minority interest income
Net income attributable to the parent company 27.70%-26.56M31.86%-14.67M-46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M
Preferred stock dividends 26.30%1.1M047.10%887K8.33%208K
Other preferred stock dividends 060K5.93M0
Net income attributable to common stockholders 29.79%-26.56M31.86%-14.67M-46.75%-6.01M-311.86%-6.45M102.41%510K-20.42%-37.82M-176.03%-21.53M7.01%-4.1M168.52%3.04M-43.37%-21.17M
Basic earnings per share 70.44%-1.6756.63%-0.8228.26%-0.33-165.00%-0.52055.86%-5.65-18.17%-1.890864.62%-0.46127.59%0.837.11%-6.1
Diluted earnings per share 70.44%-1.6756.63%-0.8228.26%-0.3365.33%-0.5291.80%-0.555.86%-5.65-18.17%-1.890864.62%-0.4648.28%-1.537.11%-6.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +14.20%
Sample Name
Sample Code
 +14.18%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+10.58%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.71%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.01%
Sample Name
Sample Code
 +20.15%
Sample Name
Sample Code
 +14.82%
4
ASE Technology
ASX
+11.17%
5
Luckin Coffee
LKNCY
+10.14%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -